Crinetics Pharmaceuticals Files 8-K
Ticker: CRNX · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: CRNX
TL;DR
CRNX filed an 8-K, standard reporting, no new news.
AI Summary
Crinetics Pharmaceuticals, Inc. filed an 8-K on June 30, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for the period ending June 30, 2025.
Why It Matters
This filing indicates Crinetics Pharmaceuticals is meeting its regulatory reporting obligations. It does not contain new material information that would immediately impact the company's stock price.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events, risks, or financial information.
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Registrant
- June 30, 2025 (date) — Date of earliest event reported
- 6055 Lusk Boulevard, San Diego, California 92121 (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing?
This 8-K filing serves to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits as of June 30, 2025.
What is the exact date of the earliest event reported?
The date of the earliest event reported is June 30, 2025.
What is the principal executive office address for Crinetics Pharmaceuticals, Inc.?
The principal executive offices are located at 6055 Lusk Boulevard, San Diego, California 92121.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 26-3744114.
Under which sections of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).